Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:INWK

InnerWorkings (INWK) Stock Price, News & Analysis

InnerWorkings logo

About InnerWorkings Stock (NASDAQ:INWK)

Advanced Chart

Key Stats

Today's Range
$2.99
$2.99
50-Day Range
$2.83
$3.00
52-Week Range
$0.87
$5.81
Volume
N/A
Average Volume
489,347 shs
Market Capitalization
$158.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive INWK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InnerWorkings and its competitors with MarketBeat's FREE daily newsletter.

INWK Stock News Headlines

Learn more about what we do
Enova Announces New Board Member Lindsay Corby
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
HiBid Appoints Pat McCusker as Chief Executive Officer
Biology KS3 & KS4: The human eye
See More Headlines

INWK Stock Analysis - Frequently Asked Questions

InnerWorkings, Inc. (NASDAQ:INWK) issued its quarterly earnings data on Tuesday, June, 16th. The business services provider reported $0.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.00 by $0.04. The business services provider earned $261.36 million during the quarter, compared to the consensus estimate of $261.40 million. InnerWorkings had a negative net margin of 1.81% and a positive trailing twelve-month return on equity of 0.46%.

Based on aggregate information from My MarketBeat watchlists, some other companies that InnerWorkings investors own include Adamis Pharmaceuticals (ADMP), Ampio Pharmaceuticals (AMPE), Cerecor (CERC), Allena Pharmaceuticals (ALNA), CTI BioPharma (CTIC), Genocea Biosciences (GNCA) and Rigel Pharmaceuticals (RIGL).

Company Calendar

Last Earnings
6/16/2020
Today
7/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Business Services
Sub-Industry
Commercial Printing
Current Symbol
NASDAQ:INWK
Fax
N/A
Employees
2,100
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
21.36
P/E Growth
1.07
Net Income
-$10.07 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.16 billion
Cash Flow
$0.38 per share
Price / Cash Flow
7.82
Book Value
$3.42 per share
Price / Book
0.87

Miscellaneous

Free Float
N/A
Market Cap
$158.00 million
Optionable
Optionable
Beta
2.53
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:INWK) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners